Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • neveaire
    Junior Member
    • Jan 2010
    • 6

    #1

    total RNA quality for library construction

    Hi Everyone -

    I've been given some RNA that was extracted from snap frozen mouse muscle (leg). The bioanalyzer tells me that the RNA is degraded (RIN ~2.5-3) with fragment sizes centered around 200-500 bases. Is it possible to make a library out of this? Ideally I'd like to ribodeplete the sample first.

    Any thoughts appreciated.
  • mnkyboy
    Member
    • Mar 2009
    • 87

    #2
    It is possible if you follow a standard Illumina RNA prep then DSN treat that may help you with your degraded sample (also well help with ribosomal).

    This is a method that works very well for FFPE samples and may work with degraded RNA.

    Comment

    • neveaire
      Junior Member
      • Jan 2010
      • 6

      #3
      Can you explain why DSN might help with degraded RNA? I understand the steps involved but not the reasoning.

      Originally posted by mnkyboy View Post
      It is possible if you follow a standard Illumina RNA prep then DSN treat that may help you with your degraded sample (also well help with ribosomal).

      This is a method that works very well for FFPE samples and may work with degraded RNA.

      Comment

      • mnkyboy
        Member
        • Mar 2009
        • 87

        #4
        I think it will remove most of your abundant products of RNA degradation allowing the lower mass amount of intact RNA to be detected. This was something Illumina claims and I have not tested it yet. They say DSN works for all low quality RNA samples including FFPE.

        Comment

        • pmiguel
          Senior Member
          • Aug 2008
          • 2328

          #5
          If you denature a DNA sample and then allow renaturation for a limited amount of time, only those fragments of DNA that are most highly reiterated (high copy) in a sample will have time to form double stranded DNA. Why? Just because high copy fragments in a solution have a better chance of colliding with a complement than low copy--it takes them less time to do so.

          Ribo depletion methods generally rely on the ribosomal RNA being intact because they bind a just a few sites on the large and small ribosomal sub-unit RNAs. If you had biotinylated oligos that bound every segment of the ribosomal RNA, then you could remove it all no matter how degraded it was.

          A DSN, "Double Stranded Nuclease" will degrade the double stranded stuff, leaving lower copy DNA behind.

          In just about any total RNA sample >85% of the RNA will be ribosomal RNA. So even if you completely skip ribo depletion, DSN normalization will degrade most of the rRNA cDNA before anything else.

          The down-side is that once you normalize, you no longer can obtain quantitative data from your RNA-seq sample because you have heavily biased downward the higher copy RNA counts. But for de novo transcriptome work, it could work fine.


          --
          Phillip
          Last edited by pmiguel; 04-06-2011, 03:54 AM.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          36 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Working...